These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 4928248

  • 1. [Asparaginase, leukemia and cancer].
    Levy D, Boiron M.
    Bull Cancer; 1969; 56(4):365-74. PubMed ID: 4928248
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease.
    Haskell CM, Canellos GP, Leventhal BG, Carbone PP, Block JB, Serpick AA, Selawry OS.
    N Engl J Med; 1969 Nov 06; 281(19):1028-34. PubMed ID: 4898857
    [No Abstract] [Full Text] [Related]

  • 8. Antitumor activity and other biologic properties of L-asparaginase (NSC-109229)-a review.
    Adamson RH, Fabro S.
    Cancer Chemother Rep; 1968 Oct 06; 52(6):617-26. PubMed ID: 4895425
    [No Abstract] [Full Text] [Related]

  • 9. [Results of an experimental study of the antitumor activity of 1-asparaginase from E. coli and Erw. carotovora].
    Terent'eva TG, Sokolov AB, Navashin SM.
    Antibiotiki; 1977 Jan 06; 22(1):78-81. PubMed ID: 320935
    [Abstract] [Full Text] [Related]

  • 10. In vitro test for sensitivity of leukemic cells to L-asparaginase.
    Schrek R, Dolowy WC.
    Cancer Res; 1971 May 06; 31(5):523-6. PubMed ID: 4932205
    [No Abstract] [Full Text] [Related]

  • 11. Report from Sloan-Kettering Institute. Enzyme therapy and nutritional depletion of tumors.
    Clin Bull; 1974 May 06; 4(2):74-6. PubMed ID: 4370337
    [No Abstract] [Full Text] [Related]

  • 12. [Antitumor activity of prospidin].
    Sorkina IuA, Chernov VA, Grushina AA, Khramchenkova SP.
    Vopr Onkol; 1970 May 06; 16(7):83-6. PubMed ID: 5274101
    [No Abstract] [Full Text] [Related]

  • 13. Screening data from the Cancer Chemotherapy National Service Center screening laboratories. XL. Plant extracts.
    Abbott BJ, Hartwell JL, Leiter J, Perdue RE, Schepartz SA.
    Cancer Res; 1967 Mar 06; 27(3 Pt 2):190-345. PubMed ID: 4289800
    [No Abstract] [Full Text] [Related]

  • 14. Antitumor effects of methylglyoxal-bis(N-4-methylthiosemicarbazone) and their potentiation in pyridoxine-deficient animals.
    Mihich E, Nichol CA.
    Cancer Res; 1965 Jul 06; 25(6):794-801. PubMed ID: 5214034
    [No Abstract] [Full Text] [Related]

  • 15. Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XLI. Plant extracts.
    Abbott BJ, Hartwell JL, Leiter J, Spetzman LA, Schepartz SA.
    Cancer Res; 1967 May 06; 27(5 Pt 2):364-527. PubMed ID: 4290629
    [No Abstract] [Full Text] [Related]

  • 16. [Antineoplastic antibiotics from Streptomycetes].
    Strauss D.
    Arzneimittelforschung; 1970 Mar 06; 20(3):301-16. PubMed ID: 4315126
    [No Abstract] [Full Text] [Related]

  • 17. Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors.
    Clarkson B, Krakoff I, Burchenal J, Karnofsky D, Golbey R, Dowling M, Oettgen H, Lipton A.
    Cancer; 1970 Feb 06; 25(2):279-305. PubMed ID: 4905154
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition by hydrazine sulfate and various hydrazides, of in vivo growth of Walker 256 intramuscular carcinoma, B-16 melanoma, Murphy-Sturm lymphosarcoma and L-1210 solid leukemia.
    Gold J.
    Oncology; 1973 Feb 06; 27(1):69-80. PubMed ID: 4739164
    [No Abstract] [Full Text] [Related]

  • 19. Clinical experience with L-asparaginase.
    Carbone PP, Haskell CM, Leventhal BG, Block JB, Selawry OS.
    Recent Results Cancer Res; 1970 Feb 06; 33():236-43. PubMed ID: 4949163
    [No Abstract] [Full Text] [Related]

  • 20. [Toxicologic study and experimental antitumor activity of rubidomycin (13,057 R.P.)].
    Maral R, Bourat G, Ducrot R, Fournel J, Ganter P, Julou L, Koenig F, Myon J, Pascal S, Pasquet J, Populaire P, de Ratuld Y, Werner GH.
    Pathol Biol; 1967 Oct 06; 15(19):903-8. PubMed ID: 4296784
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.